|
Monday, January 19, 2009
Embassy Suites, Chesterbrook, Pennsylvania (directions)
|
Contura International A/S
A medical device company
About
|
Contura International A/S is a privately held medical device company based in Copenhagen with a portfolio of brands using patented hydrogels which add tissue volume to aging tissue and muscle.
Its first brand Aquamid is a dermal tissue filler which eliminates wrinkles, lines, and adds volume for beauty enhancement. The US market for fillers is about $750 million and the well known brands are Restylane and Juvaderm. Aquamid has unique benefits: it is a versatile volumizer, gives a natural look and feel, and provides lasting enhancement. It is injected into the subcutaneous tissue and is non-resorbable. It has sales in Europe and Asia. Recently Contura completed the Aquamid pivotal trial for a PMA to the FDA. It may launch in 2010. It seeks a US marketing partner for licensing. The target customers are plastic surgeons, dermatologists, and ENTs.
A second brand Bulkamid was licensed to J&J which has launched it in Europe. Bulkamid is injected into the urethral neck and cures or improves urinary incontinence.
The research portfolio has 3 to 5 other applications of hydrogel versions with US market potentials of annual sales between $10 million and $500+ million . The websites are: www.contura.com, www.aquamid.com
3 Major Issues
|
-
Should Contura seek a US partner with competitive fillers & position Aquamid as a niche add-on? Or, should the priority be to find a company involved in other businesses that sell to the target customers and where Aquamid would have higher priority in the product lines?
-
Should Contura continue to seek a marketing partner for each new application or should it seek a partner for the whole company excepting the current license arrangement? Can the US business be separated from the European & Asian businesses for licensing purposes?
-
What funding or partnering options are available to Contura to fund the Research portfolio of 3 to 5 new applications in the next 2 to 3 years?
Program:
|
6:30 - Cocktails & Dinner (Cash bar and special 2-entree buffet menu)
8:00 - Diana Mackie, Business Development for Contura US, and Principal, Health Matters, International; and Silvia Codony, Clinical Research Director, NA, Contura Inc., will deliver the Company's "Elevator" Pitch to the Group
8:15 - A Panel will address 3 Major Issues for the Company
9:00 - Open discussion: members and guests
<Top of the page>
|
 |
|
 Slides
Contura Presentation Slides
 Audio
None available at this time
 Video
None available at this time
 Webcast
None available at this time
|
|
Contact Info:
Contura International A/S
Web: www.contura.com
Ms. Silvia Codony
Clinical Research Director
Tel: 201-633-8691 or 201-633-8697
Cell: 646-912-2994
Diana Mackie
Contura Business Development & Health Matters, International
Tel: 215-540-8148
Cell: 215-500-4338
Pat Nasshorn
Contura Business Development & Care Capital
Cell: 215-588-8484
|
|
Mark Baglin
Michael Becker
Joe Chera
Silvia Codony Presenter
Brenda Gavin
Al Giovenella
Alan Goldberg
Boas Gonen
Jim Hand
Karen Hanson (Panelist)
Dianne Harris
Dale Hartupee
Phyllis Hsieh
Jun Huangpu
Glenn Hughes
Joe Johnson
Diana Mackie (Presenter)
Alice Marcy
Christopher Maurer
Jerry McLaughlin
Robin Mitchell
Bill Moore
Donna Moncuso
Pat Nasshorn
Adele Oliva
Joe Patterson
Donna Piper
Mike Pischl
Nanda Ramanujam
Tracy Shickel
Frank Settineri
Jim Sharpe
Marvin Siegel
Don Skerrett
Gretchen Temeles
Sage Thompson
Tom Thompson
Peter van der Kam
Jordan Warshafsky (Panelist)
John Weber (Panelist )
Josh Weinstein
Eric Wyrosdic
Joe Zindulis
|
